I-131 Approval Trends Brief: early read on a thin sample
This week's I-131 sample is preliminary (the latest week is well below the prior 12-week median). The deeper narrative could not be assembled this run; readers should treat the charts below as a tentative signal rather than a settled trend.
This issue presents the I-131 weekly approval data as an early read because the latest week's sample is thin. The narrative pipeline did not produce a confident interpretation, so we surface the data without commentary. The charts below carry the same numbers the writer would have summarised: 12-week median trend, stage durations, and RFE (Request for Evidence) outcomes. Treat them as preliminary until next week's data is in.
- I-131 data published for the current ISO week as scheduled.
- Narrative pipeline degraded this run; the deeper analysis is unavailable for this issue.
- Underlying data is intact: the figures referenced below carry the week's actual numbers.
Weekly snapshot
This section presents I-131's 12-week median trend and the underlying weekly counts. The narrative read on the trend is not available for this issue; refer to the chart for the raw numbers.
Where time is spent
Stage durations measure the time cases spent at each last reported status before either advancing or being approved. The chart below presents the median, p25 (the 25th percentile), and p75 (the 75th percentile) days per stage.
Preview
Unlock the rest of this brief
Subscribers see the full analysis, including detailed forecasts and personalised case lookup.
- Full premium analysis: outlook, what it means for you, and implications.
- Personalised case lookup against this week's cohort, with percentile and remaining days.
- Estimated approval window mapped to your filing date.